Published in Clinical Oncology Week, April 28th, 2008
Brilliant II reagents offer improved performance with earlier threshold cycle (Ct) detection across a wide dynamic range. The reagents utilize a streamlined protocol to increase speed to result. The expanded product line includes...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.